vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and HEALTHSTREAM INC (HSTM). Click either name above to swap in a different company.
HEALTHSTREAM INC is the larger business by last-quarter revenue ($79.7M vs $43.6M, roughly 1.8× GRAIL, Inc.). On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs 7.4%). HEALTHSTREAM INC produced more free cash flow last quarter ($13.0M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 4.7%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
HealthStream Inc is a leading U.S.-based provider of workforce development, compliance, and training solutions tailored for the healthcare industry. It offers cloud-based platforms covering clinical skill training, talent management, patient safety education, and regulatory adherence tools, serving over 4,000 healthcare organizations including hospitals, clinics, and long-term care facilities nationwide.
GRAL vs HSTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $79.7M |
| Net Profit | $-99.2M | — |
| Gross Margin | — | — |
| Operating Margin | -285.4% | 3.0% |
| Net Margin | -227.5% | — |
| Revenue YoY | 14.0% | 7.4% |
| Net Profit YoY | -2.2% | — |
| EPS (diluted) | $-2.37 | $0.09 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $79.7M | ||
| Q3 25 | $36.2M | $76.5M | ||
| Q2 25 | $35.5M | $74.4M | ||
| Q1 25 | $31.8M | $73.5M | ||
| Q4 24 | $38.3M | $74.2M | ||
| Q3 24 | $28.7M | $73.1M | ||
| Q2 24 | $32.0M | $71.6M | ||
| Q1 24 | $26.7M | $72.8M |
| Q4 25 | $-99.2M | — | ||
| Q3 25 | $-89.0M | $6.1M | ||
| Q2 25 | $-114.0M | $5.4M | ||
| Q1 25 | $-106.2M | $4.3M | ||
| Q4 24 | $-97.1M | — | ||
| Q3 24 | $-125.7M | $5.7M | ||
| Q2 24 | $-1.6B | $4.2M | ||
| Q1 24 | $-218.9M | $5.2M |
| Q4 25 | -285.4% | 3.0% | ||
| Q3 25 | -346.2% | 9.9% | ||
| Q2 25 | -446.9% | 7.9% | ||
| Q1 25 | -482.5% | 6.0% | ||
| Q4 24 | -358.0% | 6.3% | ||
| Q3 24 | -640.5% | 8.9% | ||
| Q2 24 | -5133.8% | 6.2% | ||
| Q1 24 | -851.1% | 7.8% |
| Q4 25 | -227.5% | — | ||
| Q3 25 | -245.8% | 8.0% | ||
| Q2 25 | -320.7% | 7.2% | ||
| Q1 25 | -333.6% | 5.9% | ||
| Q4 24 | -253.8% | — | ||
| Q3 24 | -438.7% | 7.8% | ||
| Q2 24 | -4958.8% | 5.8% | ||
| Q1 24 | -819.3% | 7.2% |
| Q4 25 | $-2.37 | $0.09 | ||
| Q3 25 | $-2.46 | $0.20 | ||
| Q2 25 | $-3.18 | $0.18 | ||
| Q1 25 | $-3.10 | $0.14 | ||
| Q4 24 | $-1.49 | $0.16 | ||
| Q3 24 | $-3.94 | $0.19 | ||
| Q2 24 | $-51.06 | $0.14 | ||
| Q1 24 | $-7.05 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $36.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.6B | $354.0M |
| Total Assets | $2.9B | $520.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $36.2M | ||
| Q3 25 | $126.9M | $53.5M | ||
| Q2 25 | $127.4M | $52.1M | ||
| Q1 25 | $133.9M | $77.3M | ||
| Q4 24 | $214.2M | $59.5M | ||
| Q3 24 | $853.6M | $57.5M | ||
| Q2 24 | $958.8M | $46.1M | ||
| Q1 24 | $199.7M | $52.4M |
| Q4 25 | $2.6B | $354.0M | ||
| Q3 25 | $2.2B | $349.2M | ||
| Q2 25 | $2.3B | $350.6M | ||
| Q1 25 | $2.4B | $362.8M | ||
| Q4 24 | $2.5B | $359.4M | ||
| Q3 24 | $2.6B | $355.5M | ||
| Q2 24 | $2.7B | $349.2M | ||
| Q1 24 | — | $344.9M |
| Q4 25 | $2.9B | $520.4M | ||
| Q3 25 | $2.6B | $499.9M | ||
| Q2 25 | $2.7B | $500.1M | ||
| Q1 25 | $2.8B | $524.0M | ||
| Q4 24 | $3.0B | $510.8M | ||
| Q3 24 | $3.1B | $502.8M | ||
| Q2 24 | $3.3B | $499.6M | ||
| Q1 24 | — | $511.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $13.2M |
| Free Cash FlowOCF − Capex | $-63.9M | $13.0M |
| FCF MarginFCF / Revenue | -146.5% | 16.3% |
| Capex IntensityCapex / Revenue | 0.2% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $59.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $13.2M | ||
| Q3 25 | $-63.2M | $18.0M | ||
| Q2 25 | $-77.0M | $5.0M | ||
| Q1 25 | $-95.0M | $27.1M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $-104.6M | $19.1M | ||
| Q2 24 | $-171.8M | $6.5M | ||
| Q1 24 | $-207.3M | $20.9M |
| Q4 25 | $-63.9M | $13.0M | ||
| Q3 25 | $-63.6M | $17.9M | ||
| Q2 25 | $-77.3M | $2.7M | ||
| Q1 25 | $-95.1M | $26.0M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | $-105.6M | $18.8M | ||
| Q2 24 | $-173.2M | $6.3M | ||
| Q1 24 | $-209.8M | $20.2M |
| Q4 25 | -146.5% | 16.3% | ||
| Q3 25 | -175.8% | 23.4% | ||
| Q2 25 | -217.6% | 3.6% | ||
| Q1 25 | -298.6% | 35.4% | ||
| Q4 24 | — | 14.8% | ||
| Q3 24 | -368.4% | 25.8% | ||
| Q2 24 | -541.7% | 8.8% | ||
| Q1 24 | -785.3% | 27.8% |
| Q4 25 | 0.2% | 0.3% | ||
| Q3 25 | 1.1% | 0.1% | ||
| Q2 25 | 1.0% | 3.1% | ||
| Q1 25 | 0.2% | 1.4% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | 3.4% | 0.4% | ||
| Q2 24 | 4.3% | 0.2% | ||
| Q1 24 | 9.5% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 2.96× | ||
| Q2 25 | — | 0.93× | ||
| Q1 25 | — | 6.25× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.34× | ||
| Q2 24 | — | 1.55× | ||
| Q1 24 | — | 4.01× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
HSTM
| Subscription Services | $77.0M | 97% |
| Professional Services | $2.7M | 3% |
